Home › Compare › MEDIF vs ADC

MEDIF vs ADC: Dividend Comparison 2026

MEDIF yields 4345.46% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MEDIF wins by $15969693446288.61M in total portfolio value
10 years
MEDIF
MEDIF
● Live price
4345.46%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15969693446288.79M
Annual income
$15,278,069,441,942,714,000.00
Full MEDIF calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — MEDIF vs ADC

📍 MEDIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMEDIFADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MEDIF + ADC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MEDIF pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDIF
Annual income on $10K today (after 15% tax)
$369,364.48/yr
After 10yr DRIP, annual income (after tax)
$12,986,359,025,651,306,000.00/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, MEDIF beats the other by $12,986,359,025,651,237,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDIF + ADC for your $10,000?

MEDIF: 50%ADC: 50%
100% ADC50/50100% MEDIF
Portfolio after 10yr
$7984846723144.49M
Annual income
$7,639,034,720,971,397,000.00/yr
Blended yield
95.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

MEDIF
No analyst data
Altman Z
-2.9
Piotroski
2/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDIF buys
0
ADC buys
0
No recent congressional trades found for MEDIF or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMEDIFADC
Forward yield4345.46% ✓4.13%
Annual dividend / share$2.00$3.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4% ✓
Portfolio after 10y$15969693446288.79M ✓$178.9K
Annual income after 10y$15,278,069,441,942,714,000.00 ✓$80,797.29
Total dividends collected$15922667488789.34M ✓$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: MEDIF vs ADC ($10,000, DRIP)

YearMEDIF PortfolioMEDIF Income/yrADC PortfolioADC Income/yrGap
1← crossover$445,246$434,546.44$10,990$580.36+$434.3K → MEDIF
2$18,558,681$18,082,267.04$12,301$860.26+$18.55M → MEDIF
3$724,251,944$704,394,155.22$14,104$1,298.62+$724.24M → MEDIF
4$26,465,566,588$25,690,617,008.13$16,691$2,008.16+$26465.55M → MEDIF
5$905,687,152,836$877,368,996,586.58$20,580$3,205.09+$905687.13M → MEDIF
6$29,029,592,495,582$28,060,507,242,048.22$26,754$5,330.02+$29029592.47M → MEDIF
7$871,632,797,918,927$840,571,133,948,653.80$37,196$9,345.14+$871632797.88M → MEDIF
8$24,520,223,407,609,444$23,587,576,313,836,190.00$56,244$17,523.09+$24520223407.55M → MEDIF
9$646,377,574,155,211,500$620,140,935,109,069,400.00$94,286$35,736.21+$646377574155.12M → MEDIF
10$15,969,693,446,288,792,000$15,278,069,441,942,714,000.00$178,949$80,797.29+$15969693446288.61M → MEDIF

MEDIF vs ADC: Complete Analysis 2026

MEDIF — Stock

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

Full MEDIF Calculator →

ADC — REIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this MEDIF vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDIF vs SCHDMEDIF vs JEPIMEDIF vs OMEDIF vs KOMEDIF vs MAINMEDIF vs NNNMEDIF vs EPRTMEDIF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.